Cooperative Distributed Beamforming Design for Multi-RIS Aided Cell-Free Systems

Cell-free systems significantly improve network capacity by enabling joint user service without cell boundaries,eliminating intercell interference.However,to satisfy further capacity demands,it leads to high-cost problems of both hardware and power consumption.In this paper,we investigate multiple reconfigurable intelligent surfaces(RISs)aided cell-free systems where RISs are introduced to improve spectrum efficiency in an energy-efficient way.To overcome the centralized high complexity and avoid frequent information exchanges,a cooperative distributed beamforming design is proposed to maximize the weighted sum-rate performance.In particular,the alternating optimization method is utilized with the distributed closed-form solution of active beamforming being derived locally at access points,and phase shifts are obtained centrally based on the Riemannian conjugate gradient(RCG)manifold method.Simulation results verify the effectiveness of the proposed design whose performance is comparable to the centralized scheme and show great superiority of the RISs-aided system over the conventional cellular and cell-free system.

Cell-free biocatalysis coupled with photo-catalysis and electro-catalysis: Efficient CO_(2)-to-chemical conversion

The increasing atmospheric carbon dioxide (CO_(2)) concentration has exposed a series of crises in the earth's ecological environment.How to effectively fix and convert carbon dioxide into products with added value has attracted the attention of many researchers.Cell-free enzyme catalytic system coupled with electrical and light have been a promising attempt in the field of biological carbon fixation in recent years.In this review,the research progresses of photoenzyme catalysis,electroenzyme catalysis and photo-electroenzyme catalysis for converting carbon dioxide into chemical products in cell-free systems are systematically summarized.We focus on reviewing and comparing various coupling methods and principles of photoenzyme catalysis and electroenzyme catalysis in cell-free systems,especially the materials used in the construction of the coupling system,and analyze and point out the characteristics and possible problems of different coupling methods.Finally,we discuss the major challenges and prospects of coupling physical signals and cell-free enzymatic catalytic systems in the field of CO_(2) fixation,suggesting possible strategies to improve the carbon sequestration capacity of such systems.

Optimal AP Deployment in Cell-Free Massive MIMO Systems with LoS/NLoS Transmissions:A Stochastic Geometry Approach

Cell-free massive multiple-input multipleoutput(MIMO)is a promising technology for future wireless communications,where a large number of distributed access points(APs)simultaneously serve all users over the same time-frequency resources.Since users and APs may locate close to each other,the line-of-sight(Lo S)transmission occurs more frequently in cell-free massive MIMO systems.Hence,in this paper,we investigate the cell-free massive MIMO system with Lo S and non-line-of-sight(NLo S)transmissions,where APs and users are both distributed according to Poisson point process.Using tools from stochastic geometry,we derive a tight lower bound for the user downlink achievable rate and we further obtain the energy efficiency(EE)by considering the power consumption on downlink payload transmissions and circuitry dissipation.Based on the analysis,the optimal AP density and AP antenna number that maximize the EE are obtained.It is found that compared with the previous work that only considers NLo S transmissions,the actual optimal AP density should be much smaller,and the maximized EE is actually much higher.

Secure symbol level precoding for cell-free network based on band-region constraint of the eavesdropper’s receiving signal

A symbol level secure precoding scheme based on band-region constraint of the eavesdropper’s receiving signal is proposed to enhance the energy efficiency of cell-free multiple-input multiple-output(MIMO)networks in the presence of an eavesdropper while guaranteeing the quality of service(QoS)of user and the security of system.Moreover,to lighten its high computational complexity,original problem is divided into several cascade sub-problems firstly,and then those sub-problems are handled by combining Lagrangian dual function and improved Hooke-Jeeves method together.Comparative ex-periment with other secure symbol-level precoding schemes demonstrate that proposed scheme can achieve the lower power consumption with almost same symbol error rate and QoS of user.

Clinical use of donor-derived cell-free DNA in kidney transplantation

Traditional monitoring of kidney transplant recipients for allograft dysfunction caused by rejection involves serial checks of serum creatinine with biopsy of the renal allograft if dysfunction is suspected.This approach is labor-intensive,invasive and costly.In addition,because this approach relies on a rise in serum creatinine above historical baselines,injury to the allograft can be extensive before this rise occurs.In an effort to address this,donor-derived cell-free DNA(dd-cf DNA)is being used with increasing frequency in the clinical setting as a means of diagnosing a rejection of the renal allograft early in the course.This can poten-tially allow for early intervention to minimize not only injury,but the intensity of antirejection therapy needed and the avoidance of side effects.Here,we will review the available methodology for the determination and quantification of dd-cf DNA,the data supporting its use in clinical practice and the limitations of this technology.

RIS-Assisted Cell-Free MIMO: A Survey

Cell-free(CF)multiple-input multiple-output(MIMO)is a promising technique to enable the vision of ubiquitous wireless connectivity for next-generation network communications.Compared to traditional co-located massive MIMO,CF MIMO allows geographically distributed access points(APs)to serve all users on the same time-frequency resource with spatial multiplexing techniques,resulting in better performance in terms of both spectral efficiency and coverage enhancement.However,the performance gain is achieved at the expense of deploying more APs with high cost and power consumption.To address this issue,the recently proposed reconfigurable intelligent surface(RIS)technique stands out with its unique advantages of low cost,low energy consumption and programmability.In this paper,we provide an overview of RIS-assisted CF MIMO and its interaction with advanced optimization designs and novel applications.Particularly,recent studies on typical performance metrics such as energy efficiency(EE)and spectral efficiency(SE)are surveyed.Besides,the application of RIS-assisted CF MIMO techniques in various future communication systems is also envisioned.Additionally,we briefly discuss the technical challenges and open problems for this area to inspire research direction and fully exploit its potential in meeting the demands of future wireless communication systems.

Joint Flexible Duplexing and Power Allocation with Deep Reinforcement Learning in Cell-Free Massive MIMO System

Network-assisted full duplex(NAFD)cellfree(CF)massive MIMO has drawn increasing attention in 6G evolvement.In this paper,we build an NAFD CF system in which the users and access points(APs)can flexibly select their duplex modes to increase the link spectral efficiency.Then we formulate a joint flexible duplexing and power allocation problem to balance the user fairness and system spectral efficiency.We further transform the problem into a probability optimization to accommodate the shortterm communications.In contrast with the instant performance optimization,the probability optimization belongs to a sequential decision making problem,and thus we reformulate it as a Markov Decision Process(MDP).We utilizes deep reinforcement learning(DRL)algorithm to search the solution from a large state-action space,and propose an asynchronous advantage actor-critic(A3C)-based scheme to reduce the chance of converging to the suboptimal policy.Simulation results demonstrate that the A3C-based scheme is superior to the baseline schemes in term of the complexity,accumulated log spectral efficiency,and stability.

Cell-free DNA in the management of prostate cancer:Current status and future prospective

Objective:With the escalating prevalence of prostate cancer(PCa)in China,there is an urgent demand for novel diagnostic and therapeutic approaches.Extensive investigations have been conducted on the clinical implementation of circulating free DNA(cfDNA)in PCa.This review aims to provide a comprehensive overview of the present state of cfDNA as a biomarker for PCa and to examine its merits and obstacles for future clinical utilization.Methods:Relevant peer-reviewed manuscripts on cfDNA as a PCa marker were evaluated by PubMed search(2010-2022)to evaluate the roles of cfDNA in PCa diagnosis,prognosis,and prediction,respectively.Results:cfDNA is primarily released from cells undergoing necrosis and apoptosis,allowing for non-invasive insight into the genomic,transcriptomic,and epigenomic alterations within various PCa disease states.Next-generation sequencing,among other detection methods,enables the assessment of cfDNA abundance,mutation status,fragment characteristics,and epigenetic modifications.Multidimensional analysis based on cfDNA can facilitate early detection of PCa,risk stratification,and treatment monitoring.However,standardization of cfDNA detection methods is still required to expedite its clinical application.Conclusion:cfDNA provides a non-invasive,rapid,and repeatable means of acquiring multidimensional information from PCa patients,which can aid in guiding clinical decisions and enhancing patient management.Overcoming the application barriers of cfDNA necessitates increased data sharing and international collaboration.

Caching modeling and energy analyzing of cell-free wireless heterogeneous networks with beta Ginibre point process

Cell-free Wireless Heterogeneous Networks(HetNets)have emerged as a technological alternative for conventional cellular networks.In this paper,we study the spatially correlative caching strategy,the energy analysis,and the impact of parameter β on the total energy cost of the cell-free wireless HetNets with Access Points distributed by Beta Ginibre Point Process(β-GPP).We derive the approximate expression of Successful Delivery Probability(SDP)based on the Signal-to-Interference-plus-Noise Ratio coverage model.From both analytical and simulation results,it is shown that the proposed caching model based on β-GPP placement,which jointly takes into account path loss,fading,and interference,can closely simulate the caching performance of the cell-free HetNets in terms of SDP.By guaranteeing the outage probability constraints,the analytical expression of the uplink energy cost is also derived.Another conclusion is that with AP locations modeled by β-GPP,the power consumption is not sensitive to β,but is sensitive to the dimension of the kernel function;hence β is less restrictive,and only the truncation of the Ginibre kernel has to be appropriately modified.These findings are new compared with the existing literature where the nodes are commonly assumed to be of Poisson Point Process,Matern Hard-Core Process,or Poisson Cluster Process deployment in cell-free systems.

Revolutionizing Non-Invasive Biomarker Discoveries: The Power of Methylation Screening Analysis in Cell-Free DNA Liquid Biopsy

Epigenetic changes of DNA, including methylation, have long been recognized as key indicators of various diseases, including aging, cancer, and neurological disorders. Biomarker discoveries based on distinct methylation patterns for both hypermethylation and hypomethylation lead the way in discovery of novel diagnosis and treatment targets. Many different approaches are present to detect the level of methylation in whole genome (whole genome bisulfite sequencing, microarray) as well as at specific loci (methylation specific PCR). Cell-free DNA (cf-DNA) found in body fluids like blood provides information about DNA methylation and serves as a less invasive approach for genetic screening. Cell-free DNA and methylation screening technologies, when combined, have the potential to transform the way we approach genetic screening and personalized therapy. These technologies can help enhance disease diagnostic accuracy and inform the development of targeted therapeutics by providing a non-invasive way for acquiring genomic information and identifying disease-associated methylation patterns. We highlight the clinical benefits of using cell-free DNA (cf-DNA) liquid biopsy analysis and available methylation screening technologies that have been crucial in identifying biomarkers for disease from patients using a non-invasive way. Powering such biomarker discoveries are various methods of cf-DNA methylation analysis such as Bisulfite Sequencing and most recently, Methylation-Specific Restriction Enzyme (MSRE-seq) Analysis, paving the way for novel epigenetic biomarker discoveries for more robust diagnosis such as early disease detection, prognosis, monitoring of disease progression and treatment response as well as discovery of novel drug targets.

Cell-free systems in the new age of synthetic biology

The advent of synthetic biology has ushered in new applications of cell-free transcription-translation systems. These cell-free systems are reconstituted using cellular proteins, and are amenable to modular control of their composition. Here, we discuss the historical advance- ment of cell-free systems, as well as their new applications in the rapid design of synthetic genetic circuits and components, directed evolution ofbiomolecules, diagnosis of infectious diseases, and synthesis of vaccines. Finally, we present our vision on the future direction of cell-free synthetic biology.

Cell lysates and egg white create homeostatic microenvironment for gene expression in cell-free system

Homeostasis widely exists in living systems,and plays essential roles for maintaining normal physiological activities,enabling to preserve their functionalities against variations.Gene expression is a crucial process that allows cells to produce the necessary protein,giving cells the flexibility to adapt to variations.Herein we study homeostasis of gene expression in cell-free system.Heat-inactivated cell lysates and egg white are utilized to create homeostatic microenvironment.Results show that both in cell lysates and egg white,gene expression is maintained at relatively stable levels upon variations including gene amount,magnesium ions and temperature.Our work presents a nascent concept and experimental evidence for the homeostasis in cell-free systems,and provides implication for living systems.

Nuclear assembly of purified Crythecodinium cohnii chromosomes in cell-free extracts of Xenopus laevis eggs

Incubation of dinoflagellate Crythecodinium cohnii chromosomes in cytoplasmic extracts of unfertilized Xenopus laevis eggs resulted in chromosomes decondensation and recondensation, nuclear envelope assembly, and nuclear reconstitution.Dinoflagellate Crythecodinium cohnii is a kind of primitive eukaryote which possesses numerous permanently condensed chromosomes and discontinuous double-layered nuclear membrane throughout the cell cycle. The assembled nuclei, being surrounded by a continuous double membrane containing nuclear pores and the uniformly dispersed chromatin fibers are morphologically distinguishable from that of Dinoflagellate Crythecodinium cohnii. However, incubation of dinoflagellate Crythecodinium cohnii chromosomes in the extracts from dinoflagellate Crythecodinillm cohnii cells does not induce nuclear reconstitution.

Cell-Free大规模MIMO系统中基于传输时延的缓存策略研究

为了满足未来移动互联网中用户的超低时延和超高可靠需求,将无线缓存技术与无小区大规模多输入多输出系统相结合,设计了基于AP间协作缓存及区域流行度评估的缓存模型。推导出涉及AP分簇、协作缓存以及区域流行度的传输时延表达式,并将内容放置问题表述为最小化总内容传输时延问题。通过对优化问题的NP-hard和拟阵约束下次模单调性的证明,提出了基于贪婪算法的缓存部署优化策略。仿真结果表明,所提策略可有效降低系统内容传输时延和提升缓存命中率。

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids

Hepatocellular carcinoma(HCC), with its high incidence and mortality rate, is one of the most common malignant tumors. Despite recent development of a diagnostic and treatment method, the prognosis of HCC remains poor. Therefore, to provide optimal treatment for each patient with HCC, more precise and effective biomarkers are urgently needed which could facilitate a more detailed individualized decision-making during HCC treatment, including the following; risk assessment, early cancer detection, prediction of treatment or prognostic outcome. In the blood of cancer patients, accumulating evidence about circulating tumor cells and cell-free nucleic acids has suggested their potent clinical utilities as novel biomarker. This concept, so-called "liquid biopsy" is widely known as an alternative approach to cancer tissue biopsy. This method might facilitate a more sensitive diagnosis and better decision-making by obtaining genetic and epigenetic aberrations that are closely associated with cancer initiation and progression. In this article, we review recent developments based on the available literature on both circulating tumor cells and cell-free nucleic acids in cancer patients, especially focusing on Hepatocellular carcinoma.

Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine

Mesenchymal stem cells(MSCs)are multipotent stem cells with marked potential for regenerative medicine because of their strong immunosuppressive and regenerative abilities.The therapeutic effects of MSCs are based in part on their secretion of biologically active factors in extracellular vesicles known as exosomes.Exosomes have a diameter of 30-100 nm and mediate intercellular communication and material exchange.MSC-derived exosomes(MSC-Exos)have potential for cell-free therapy for diseases of,for instance,the kidney,liver,heart,nervous system,and musculoskeletal system.Hence,MSC-Exos are an alternative to MSCbased therapy for regenerative medicine.We review MSC-Exos and their therapeutic potential for a variety of diseases and injuries.

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids

Despite recent advances in surgical techniques and perioperative management, the prognosis of pancreatic cancer(PCa) remains extremely poor. To provide optimal treatment for each patient with Pca, superior biomarkers are urgently needed in all phases of management from early detection to staging, treatment monitoring, and prognosis. In the blood of patients with cancer, circulating tumor cells(CTCs) and cell-free nucleic acids(cf NAs), such as DNA, m RNA, and noncoding RNA have been recognized. In the recent years, their presence in the blood has encouraged researchers to investigate their potential use as novel blood biomarkers, and numerous studies have demonstrated their potential clinical utility as a biomarker for certain types of cancer. This concept, called "liquid biopsy" has been focused on as a less invasive, alternative approach to cancer tissue biopsy for obtaining genetic and epigenetic aberrations that contribute to oncogenesis and cancer progression. In this article, we review the available literature on CTCs and cfN As in patients with cancer, particularly focusing on PCa, and discuss future perspectives in this field.

Liquid biopsy of gastric cancer patients:Circulating tumor cells and cell-free nucleic acids

To improve the clinical outcomes of cancer patients, early detection and accurate monitoring of diseases are necessary. Numerous genetic and epigenetic alterations contribute to oncogenesis and cancer progression, and analyses of these changes have been increasingly utilized for diagnostic, prognostic and therapeutic purposes in malignant diseases including gastric cancer (GC). Surgical and/or biopsy specimens are generally used to understand the tumor-associated alterations; however, those approaches cannot always be performed because of their invasive characteristics and may fail to reflect current tumor dynamics and drug sensitivities, which may change during the therapeutic process. Therefore, the importance of developing a non-invasive biomarker with the ability to monitor real-time tumor dynamics should be emphasized. This concept, so called “liquid biopsy”, would provide an ideal therapeutic strategy for an individual cancer patient and would facilitate the development of “tailor-made” cancer management programs. In the blood of cancer patients, the presence and potent utilities of circulating tumor cells (CTCs) and cell-free nucleic acids (cfNAs) such as DNA, mRNA and microRNA have been recognized, and their clinical relevance is attracting considerable attention. In this review, we discuss recent developments in this research field as well as the relevance and future perspectives of CTCs and cfNAs in cancer patients, especially focusing on GC.

Wireless Powered IoE for 6G: Massive Access Meets Scalable Cell-Free Massive MIMO

A key challenge to the scalable deployment of the energy self-sustainability(ESS)Internet of Everything(IoE)for sixth-generation(6G)networks is juggling massive connectivity and high spectral efficiency(SE).Cell-free massive multiple-input multiple-output(CF mMIMO)is considered as a promising solution,where many wireless access points perform coherent signal processing to jointly serve the users.However,massive connectivity and high SE are difficult to obtain at the same time because of the limited pilot resource.To solve this problem,we propose a new framework for ESS IoE networks where the user activity detection(UAD)and channel estimation are decoupled.A UAD detector based on deep convolutional neural networks,an initial access scheme,and a scalable power control policy are proposed to enable the practical scalable CF mMIMO implementation.We derive novel and exact closed-form expressions of harvested energy and SE with maximum ratio(MR)processing.Using local partial minimum mean-square error and MR combining,simulation results prove that the proposed framework can serve more users,improve the SE performance,and achieve better user fairness for the considered ESS IoE networks.

Quick recovery and characterization of cell-free DNA in seminal plasma of normozoospermia and azoospermia： implications for non-invasive genetic utilities

We established a quick and reliable method for recovering cell-free seminal DNA （cfsDNA）, by using the binding-washing-elution procedure on the DNA purification column. Low variations （below 15%） among the triplicate values of cfsDNA quantity verified the reproducibility of our cfsDNA recovery method. Similar cfsDNA yield and size distribution between seminal plasma acquired by filtration and centrifugation confirmed the presence of cfsDNA. To investigate the general characterization of cfsDNA, the quantitation and size distribution of cfsDNA from normozoospermic and azoospermic semen were analyzed by real-time PCR and electrophoresis, respectively. CfsDNA concentration in semen with normozoospermia （n = 11） was 1.34 ± 0.65 μg ·mL^-1, whereas a higher cfsDNA concentration was observed in azoospermia （2.56 ± 1.43 μg ·mL^-1, n = 9）. The continuous distribution of DNA fragments ranging from -1 kb to 15 kb and a spectrum of multiples of 180-bp fragments were observed in each normozoospermic and azoospermic sample. Distinct characteristic DNA ladder fragmentations in some azoospermic samples implicated that cfsDNA originate partly from apoptotic cells. CfsDNAs of 36 selected azoospermic patients with known information of Y chromosome microdeletion were subjected to the same microdeletion analysis by multiplex PCR and PCR amplification of sY114 （1 450 bp）. All multiplex PCR reactions with cfsDNA amplified successfully and provided the same result as leukocyte DNA. PCR amplification of sY114 gave a 1 450-bp amplicon as expected. Our data suggested the potential use of cfsDNA in search of biomarker or diagnostic procedures.